Dr. Hachigian is the co-founder and President of TScan Therapeutics, as well as a Principal at Longwood Fund. She received her Ph.D. from MIT in molecular and cellular neuroscience where she was an NSF Graduate Research Fellow. As a student in the Heiman Lab at the Broad Institute, Dr. Hachigian studied the determinants of neuronal identity and vulnerability in disease. Prior to her doctorate, Dr. Hachigian received an A.B. from Harvard University where she graduated magna cum laude with highest honors in Neurobiology and received a certificate in Mind Brain and Behavior. While at Harvard, Dr. Hachigian researched genetic models of developmental disorders in the Fagiolini/Hensch lab at Children’s Hospital/Harvard Medical School. She has received numerous fellowships for her research and multiple teaching awards for her work with both undergraduate and graduate students.